Skip to content

John E. Greifenkamp, MD

NPI 1396712980ActiveIndividual· Internal Medicine· Longview, TX

Internal Medicine (MD) in Longview, Texas, licensed in TX, with an NPI issued in March 2006. Part D covered 117 prescriptions written in 2024, 85% of them generic. Alnylam Pharmaceuticals Inc. was the largest of 2 companies reporting payments in 2025, $147.76 in all, mostly food and beverage.

Overview

NPI1396712980
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 2, 2006
Last updated in NPPESJan 15, 2008

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XE0479TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)117 · 199 30-day fills
Patients40
Total drug cost$12,156
Generic share85% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$147.76 · 2 payments from 2 companies
  • 2024$30.62 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Alnylam Pharmaceuticals Inc.$133.101
Philips North America LLC$14.661

What the 2025 payments were for

  • Food and Beverage$147.76 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Longview

All 119 internal medicine physicians in Longview · All internal medicine physicians in Texas